Mounjaro vs. Ozempic vs. Saxenda: a doctor’s in-depth comparison of effects, side effects and cost

  • Published:
  • Updated:
  • Written by the Hiro Clinic Medical Weight Loss editorial team
  • 51 min read
Medically reviewed by Dr. Hiroko Oka Reviewed byDr. Hiroko OkaCertified Member, Japanese Society of Internal Medicine Editorial policy
Mounjaro vs. Ozempic vs. Saxenda: a doctor’s in-depth comparison of effects, side effects and cost

In recent years, GLP-1 receptor agonists have been attracting worldwide attention in the treatment of obesity disease and type 2 diabetes. Dieting, which once required “strong willpower,” has entered an era in which medicine offers the option of “controlling appetite itself.”

In consultations, we often hear people say, “I don’t know which drug suits me best.” Interest in comparing them is growing, to the point that posts comparing several drugs can be seen on social media (@okusuri_labo). However, obtaining these drugs through personal import agents and similar routes carries quality-control risks, so when comparing options, please assume they will be prescribed by a medical institution.

Among these drugs, more and more people are comparing three in particular — Mounjaro, Ozempic and Saxenda — as having strong weight-loss effects. In this article, a doctor compares and explains the differences between these injectable drugs, as well as the oral medication Rybelsus, for a total of four drugs.

Key points firstShort on time? Just read this

  • The answer to “Which one helps you lose the most weight?” is currently Mounjaro
  • The best drug for you is largely determined by three factors: how quickly you want to lose weight, how much hassle with injections you can accept, and how worried you are about side effects
  • GLP-1 and GIP-related drugs do not replace diet or exercise therapy; they are medical support that helps you improve your lifestyle

1. [Conclusion] Comparison table of four major GLP-1 weight-loss drugs

In short: if weight loss is your top priority, Mounjaro is a candidate; if you want to minimize clinic visits and injection hassle, Ozempic or Rybelsus; and if you want to adjust the dose to how you feel each day, Saxenda. Because each drug differs in ingredient, method of administration and cost, start by getting an overview of the four drugs in the comparison table, then narrow down to the one that fits your lifestyle.

For those short on time, here is a summary of the specifications of the four main drugs.

ItemMounjaroOzempicSaxendaRybelsus
Active ingredientTirzepatideSemaglutideLiraglutideSemaglutide
Type of drugGIP/GLP-1 receptor agonistGLP-1 receptor agonistGLP-1 receptor agonistGLP-1 receptor agonist
Method of administrationSubcutaneous injectionSubcutaneous injectionSubcutaneous injectionOral (tablet)
FrequencyOnce weeklyOnce weeklyOnce dailyOnce daily
Weight-loss effect★★★ (very high)★★☆ (high)★☆☆ (standard)★☆☆ (standard)
Maximum weight loss (approx.)About 15–22%About 10–15%About 8–10%About 5–10%
Main side effectsNausea, diarrhea, constipationNausea, constipation, diarrheaNausea, vomiting, headacheNausea, abdominal pain, diarrhea
FeaturesNewest dual-action drugBalance of effect and convenienceDose can be fine-tunedBest for people who dislike injections

[Advice from the doctor]

The answer to “Which one helps you lose the most weight?” is currently Mounjaro. However, the best choice depends on your constitution, lifestyle (injection frequency and how easily you can visit a clinic) and budget.

2. Why do they cause weight loss? The science of GLP-1 and GIP

Weight comes off because these drugs act on the brain’s satiety center and suppress appetite itself. By supplementing the actions of two digestive hormones, GLP-1 and GIP, with medication, the amount you eat decreases naturally without having to hold back hard.

Before going into the details of the comparison, let’s make sure we understand the mechanism by which these drugs bring about dramatic weight loss.

What GLP-1 (glucagon-like peptide-1) does

GLP-1 is a substance released from the small intestine when you eat, sometimes called the “slimming hormone.” Its main actions are as follows.

  1. Action on the central nervous system: acts on the brain’s appetite center to increase the feeling of fullness and strongly suppress appetite.
  2. Delayed gastric emptying: encourages food in the stomach to move slowly into the duodenum, so you stay full longer.
  3. Optimized insulin secretion: promotes insulin secretion only when blood sugar is high, stabilizing blood sugar.

What GIP (glucose-dependent insulinotropic peptide) does

This component, found only in Mounjaro, is one of the incretins (digestive hormones), like GLP-1.

  • Improved energy metabolism: it has been suggested that it acts directly on fat tissue and improves lipid metabolism.
  • Fewer side effects: research is examining whether it may ease digestive symptoms such as nausea compared with GLP-1 alone.

Mounjaro is the world’s first drug with this “dual action” on GLP-1 and GIP, which is why it outperforms earlier drugs.

3. Mounjaro (active ingredient: tirzepatide) in detail

Thanks to its dual action on GLP-1 and GIP, Mounjaro has the highest reported weight-loss rate of the four drugs. However, in Japan it is approved as a treatment for type 2 diabetes, so please consider it with the understanding that use for weight loss is off-label, self-pay treatment.

Feature: a “fourth-generation” drug with the strongest weight-loss effect

Mounjaro is the newest drug, launched in 2023. By adding GIP action to that of conventional GLP-1 receptor agonists, it showed remarkable data in the SURMOUNT-1 clinical trial: at the maximum dose (15 mg), an average weight loss of 22.5% (about 22 kg) over 72 weeks.

Advantages

  • Outstanding weight-loss efficiency: further weight loss can be expected even in people whose results with other drugs had plateaued.
  • Convenience of once-weekly dosing: self-injection is needed only once a week, making it easy to manage when traveling or on business trips.
  • Metabolic improvement: it is said to improve not only blood sugar but also triglyceride and cholesterol levels.

Disadvantages

  • Unstable supply: due to excessive global demand, it may be hard to obtain at certain times.
  • Price: as the newest drug, the price per pen tends to be higher than for other drugs.

4. Ozempic (active ingredient: semaglutide) in detail

Ozempic is the once-weekly GLP-1 injection with the largest prescribing record worldwide, offering an excellent balance of effectiveness and safety. Like Mounjaro, in Japan it is approved as a treatment for type 2 diabetes; note that it is a separate product with a different approval category from Wegovy, an obesity disease treatment containing the same ingredient, semaglutide.

Feature: the trusted “standard” with a strong track record

Ozempic is one of the most prescribed GLP-1 injections in the world. Until Mounjaro appeared, it reigned as “the strongest injectable.”

Advantages

  • Stable effect with once-weekly dosing: the STEP 1 clinical trial confirmed weight loss of about 15%.
  • Cardiovascular protection: studies in people with diabetes have also reported a reduced risk of heart disease and stroke, and it has an extensive safety track record.
  • Fine dose adjustment: it uses a dial-type device that makes it easy to adjust the dose between 0.25 mg, 0.5 mg and 1.0 mg.

Disadvantages

  • Less weight loss than Mounjaro: if you are aiming for substantial weight loss of 20% or more, it falls a step short of Mounjaro.
  • Digestive symptoms: some reports indicate that a slightly higher proportion of people experience nausea early in treatment than with Mounjaro.

5. Saxenda (active ingredient: liraglutide) in detail

Saxenda is a drug that lets you adjust the dose closely with daily self-injection, but you must understand that it is an unapproved drug in Japan. While it is approved by the FDA and EMA in the US and Europe, medical institutions in Japan that handle it provide it within the framework of self-pay treatment and personal import, so check their quality-control system in advance.

Feature: a “pioneer among obesity drugs” with more than 10 years of history

Saxenda is a long-established drug that was the first in the world to be approved as an “obesity disease treatment” by the FDA (US Food and Drug Administration) and other agencies.

Advantages

  • Daily fine-tuning possible: you can fine-tune according to how you feel that day, for example, “I have a dinner today, so I want to keep some appetite” or “I feel a bit nauseous today, so I’ll reduce the amount.”
  • Short time in the body: because its half-life is short, if strong side effects do occur, the drug leaves the body quickly once you stop.
  • Low cost: because it has been used for many years, some clinics offer it at a relatively low price.

Disadvantages

  • Hassle of daily injections: you need to self-inject at the same time every day, which can be a hurdle until it becomes a habit.
  • Weight-loss effect: compared with the newest once-weekly drugs (such as Mounjaro), weight loss is modest at around 8–10%.

Not sure if it suits you? Start with a consultation.

A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.

No consultation fee (first & follow-up visits)Online consultation available

6. Rybelsus (active ingredient: semaglutide) in detail

Rybelsus is an oral GLP-1 drug for people who are reluctant to inject, but the biggest caution is that it is less likely to work if you do not follow the rules for taking it. In Japan it is approved as a treatment for type 2 diabetes, and as with the other three drugs, use for weight loss is self-pay treatment at a doctor’s discretion.

Feature: the only “oral GLP-1 weight-loss drug”

This drug was developed so that semaglutide, the same ingredient as in Ozempic, can be taken by mouth instead of by injection.

Advantages

  • No injection pain: no needles are needed, so even people who are reluctant to inject can continue with peace of mind.
  • Easy to manage: as a tablet, it is easy to carry and can be taken when you are out.

Disadvantages

  • Strict rules for taking it: unless you follow the rules — take it “on a completely empty stomach right after waking up” with “no more than 120 ml of water,” and then “no food, drink or other medications for 30 minutes to 2 hours” — almost none of the ingredient is absorbed.
  • Individual differences in absorption: absorption varies with conditions in the stomach, so a drawback is that how well it works differs more from person to person than with injectables.
Image of a doctor counseling a patient about prescribing GLP-1 receptor agonists

7. A guide to managing side effects so you don’t fail

Most side effects are temporary and ease around 2 weeks after starting, but if symptoms are strong, do not just put up with them on your own judgment; always consult the prescribing doctor. Strictly following “titration” — starting at a low dose and increasing step by step — is the most important tip for avoiding dropout and continuing treatment.

The key to successful medical weight loss is managing side effects well.

Common side effects and how to deal with them

  1. Nausea and heavy stomach:
    • The most common side effect. To counter it, it is important to “stop eating when you are about 80% full” and “avoid greasy food.” In most cases it improves within about 2 weeks.
  2. Constipation:
    • This occurs because the movement of the stomach and intestines slows. Drink plenty of fluids, and try adding dietary fiber or an over-the-counter intestinal regulator.
  3. Hypoglycemia:
    • Rare when used alone, but if you feel lightheaded or have a cold sweat, take sugar immediately.

A doctor’s tips for keeping it up

I feel it is a shame when people stop on their own judgment out of fear of side effects. At Hiro Clinic, we use “titration (dose adjustment)”: we start with a very small dose and, after waiting for the body to adjust, increase it step by step. In my own practice, my impression is that people who start with a small dose are less likely to drop out partway.

8. Which drug is best for you? [Type-based guide]

The best drug for you is largely determined by three factors: how quickly you want to lose weight, how much hassle with injections you can accept, and how worried you are about side effects. Use the type-based guide below and talk to a doctor, starting with the drug that best matches your priorities.

A: You are “serious” and want to lose the most weight in the shortest time

  • Recommended: Mounjaro
  • If your BMI is over 30, or you are 15 kg or more above your standard weight, Mounjaro’s strong effect can work in your favor.

B: You are busy with work and want to keep hassle to a minimum

  • Recommended: Ozempic
  • It requires only a once-weekly injection and offers a balance between side effects and effectiveness, making it the most popular choice among working people.

C: You are worried about side effects and want to proceed carefully

  • Recommended: Saxenda
  • Because you can control the amount yourself every day, you can work out “the right amount for you” while consulting your doctor.

D: You really dislike injections

  • Recommended: Rybelsus
  • As long as you keep to the morning routine, it is the weight-loss treatment with the lowest psychological hurdle to start.

E: You want to check whether you qualify for insurance-covered care

  • Recommended: first check the eligibility criteria for insurance-covered care
  • If you meet criteria such as BMI and coexisting conditions, obesity disease treatments with the same ingredients (such as Wegovy and Zepbound) may be covered by health insurance. Our medical weight-loss clinic offers self-pay treatment only, so if you want insurance-covered care, please also consider visiting a medical institution that provides it.

9. Typical costs and treatment duration

As a guide, plan on 3–6 months of medical weight-loss costs, including the initial consultation and test fees plus monthly drug costs. Because monthly costs differ by drug, it is important to compare total costs and choose a plan you can continue comfortably.

Medical weight loss is not something that “ends in a month.” Including the period for reaching your target weight and a rebound-prevention period to maintain it, we generally recommend continuing for 3 to 6 months.

  • Initial costs: consultation fee, test fees and the first drug cost.
  • Ongoing costs: monthly drug costs (depending on the type and dose of drug).

So that patients can continue comfortably, Hiro Clinic offers Mounjaro at a fair price that only a medical institution can offer, from ¥4,400 (tax incl.) per pen.

For reference, our prices start at ¥8,980 (tax incl.) for 30 tablets of Rybelsus 3 mg and ¥4,400 (tax incl.) per pen of Mounjaro (as of July 2026). As this is self-pay treatment, you pay the full cost, and the monthly total varies depending on the dose and number of pens. Prices may change, so always check the latest information on our official price page before signing up.

10. Summary: medical weight loss with your doctor by your side

GLP-1 and GIP-related drugs do not replace diet or exercise therapy; they are medical support that helps you improve your lifestyle. Using them on your own judgment via personal import or unapproved routes carries significant risk, so always see a medical institution and get a prescription suited to your constitution and medical history.

Mounjaro, Ozempic, Saxenda… Each of these drugs has excellent effects, but they are not “magic wands.” They show their true value only when combined with appropriate dietary management and moderate exercise.

Also, using drugs obtained through personal import or similar routes is extremely dangerous because of the risk of counterfeits and because side effects cannot be properly handled. Always get a diagnosis from a doctor at a medical institution and receive a prescription that suits you.

About self-pay treatment and off-label use

Self-pay treatment
Medical weight loss is self-pay treatment (paid in full by the patient) and is not covered by public health insurance.
Off-label use
Using medicines for weight management or weight loss may be off-label use, outside the indications approved in Japan.
Relief System for Adverse Drug Reactions
With off-label use, health damage such as a serious side effect may not be covered by Japan’s Relief System for Adverse Drug Reactions.
Individual differences and the doctor’s judgment
Effects and side effects vary from person to person. A doctor decides after a consultation whether you can use a medicine and which medicine and dose are appropriate. Please tell us in advance about any symptoms, chronic conditions or medicines you are taking.

Frequently asked questions (FAQ)

Here are questions about Mounjaro, Ozempic, Saxenda and Rybelsus that we often hear in consultations. Answers may differ depending on individual symptoms and constitution, so please ask about any concerns directly during your consultation.

QCan I change drugs partway through?
A

Yes. For example, adjustments such as “I started with Rybelsus but want a stronger effect, so I’ll switch to Mounjaro” can be made safely under a doctor’s care.

QIs it covered by health insurance?
A

It is self-pay treatment (paid out of pocket). If you have been diagnosed with type 2 diabetes, it may be covered by insurance in some cases, but our medical weight-loss clinic offers self-pay treatment only.

QWill I regain the weight?
A

If you go back to your previous eating habits as soon as you stop the medication, there is a risk of regaining weight. While you are on the medication, we also provide guidance to help you build “eating habits that make weight gain less likely.”

QAre Mounjaro and Zepbound the same drug?
A

They have the same active ingredient (tirzepatide), but in Japan Mounjaro is approved as a treatment for type 2 diabetes and Zepbound as a treatment for obesity disease, each as a separate drug. Using Mounjaro for weight loss is off-label, self-pay treatment.

QCan I get Saxenda prescribed at a hospital in Japan?
A

Saxenda is an unapproved drug in Japan, so it cannot be prescribed under regular insurance-covered care. Medical institutions that handle it provide it within the framework of self-pay treatment and personal import, and quality-control systems and prices differ between institutions, so it is important to check in advance.

QCan I use it while pregnant or breastfeeding?
A

As a rule, GLP-1 receptor agonists and GIP/GLP-1 receptor agonists are not given to people who are pregnant, trying to become pregnant, or breastfeeding. If you have a set time when you plan to try for pregnancy, consult your doctor in advance about when to stop the medication.

References

  • Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022.
  • Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021.
  • Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015.

Medically reviewed by: Dr. Hiroko Oka (Chair, Fukubikai Medical Corporation / Certified Member, Japanese Society of Internal Medicine)

Who to contact if you have side effects | When to seek medical care

If you have any of the following symptoms, contact us rather than waiting to see what happens. GIP/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly digestive symptoms. Most are mild, but serious ones occasionally occur.

SymptomPossible causeWhat to do
Ongoing nausea or vomitingDigestive symptoms; the most common side effectContact us if you remain unable to keep fluids down
Severe abdominal pain (pain that spreads to the back)Possible acute pancreatitisStop the injections immediately and seek medical care
Cold sweat, palpitations, strong hunger, feeling confused or drowsyHypoglycemiaTake sugar immediately and contact us
Skin rash, difficulty breathing, swelling of the face or throatAllergic reactionSeek medical care immediately

Contact: 0120-241-929 (9:00–18:00)
If your symptoms are severe outside these hours, go to your nearest emergency medical facility.

Direct phone numbers for each clinic are listed on the clinic information page.

References

The information about medicines in this article is based on the following official sources. For details on dosage, administration and side effects, always check the latest package insert.
Pharmaceuticals and Medical Devices Agency (PMDA), “Mounjaro Subcutaneous Injection Ateos: package insert” (Japanese)
PMDA, “Drug Guide for Patients: Mounjaro Subcutaneous Injection Ateos” (PDF, Japanese)
Ministry of Health, Labour and Welfare, “Prevention of lifestyle-related diseases” (Japanese)

Using Mounjaro for purposes other than obesity disease is self-pay treatment and is not covered by public health insurance. Effects and side effects vary from person to person.

Reviewing doctor: Hiroko Oka
Reviewing doctor

Hiroko OkaDirector, Hiro Clinic Kawaguchi (physician)

Japanese Society of Internal Medicine About our medical review and editorial policy

You may also like

Back to all articles

Ask our AI chat AI chat